The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08)-Reference-Cited by-同舟云学术

The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08)

Published:2019-10 Issue:5 Volume:19 Page:345-353.e2
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Choi Noorie,Kim Kyubo,Shin Kyung Hwan,Kim Yumi,Moon Hyeong-Gon,Park Won,Choi Doo Ho,Kim Su Ssan,Ahn Seung Do,Kim Tae Hyun,Chun Mison^ORCID,Kim Yong Bae,Kim Suzy,Choi Byung Ock,Kim Jin Hee

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases;Reinfuss;Cancer,1996

2. Histologic Typing of Breast Tumors;World Health Organization,1981

3. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins;Tan;J Clin Pathol,2012

4. World Health Organization Classification of Tumours;Lakhani,2012

5. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009;Gnerlich;Ann Surg Oncol,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent and transformation of borderline to malignant phyllodes tumour with osteoid differentiation: a case report and literature review;Frontiers in Oncology;2024-06-20

2. Predicting Prognosis of Phyllodes Tumors Using a Mammography- and Magnetic Resonance Imaging-Based Radiomics Model: A Preliminary Study;Clinical Breast Cancer;2024-05

3. Primary breast sarcomas: A 13 case-series study treated in university hospital in central Tunisia over a 25-year period;Breast Disease;2024-03-28

4. Tumeurs rares du sein;Cancer/Radiothérapie;2023-12

5. Case Report: A 13-year-old adolescent diagnosed as malignant phyllodes tumor combined with rhabdomyosarcoma differentiation;Frontiers in Oncology;2023-09-27